Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-Month follow up

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 11, 2008, Pages 1678-1682

  Bresci, Giampaolo ^a,b   Parisi, Giuseppe ^a   Mazzoni, Alessandro ^a   Scatena, Fabrizio ^a   Capria, Alfonso ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UO di Immunoematologia Azienda Ospedaliera Universitaria Pisana ^*  (Italy)

Author keywords

Granulocytapheresis; Leukocytapheresis; Methylprednisolone; Ulcerative colitis

Indexed keywords

HEPARIN; MESALAZINE; METHYLPREDNISOLONE; PREDNISOLONE;

ACNE; ACUTE DISEASE; ADULT; APHERESIS; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GLUCOSE INTOLERANCE; GRANULOCYTAPHERESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOON FACE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; ULCERATIVE COLITIS;

EID: 56549102203     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05595.x     Document Type: Article

References (30)

1. Saverymuttu SH, Chadwick VS, Hodgson HJ. Granulocyte migration in ulcerative colitis. Eur. J. Clin. Invest. 1985 15 : 60 3.
2. Saverymuttu SH, Peters AM, Crofton ME et al. 111Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut 1985 26 : 955 60.
3. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994 35 : 669 74.
4. Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Increased expression of IL-16 in inflammatory bowel disease. Gut 2001 48 : 326 32.
5. Nielsen OH, Rudiger N, Gaustadnes M, Horn T. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand. J. Gastroenterol. 1997 32 : 1028 34.
6. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998 42 : 470 6.
7. Janczewska I, Stal P, Sandstedt B Transformation of microscopic colitis to inflammatory bowel disease Lakartidningen 2007 104 (20-21 1597 8 (in Swedish).
8. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000 279 : G851 7.
9. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on therapeutic trial. Br. Med. J. 1955 2 : 1041 8.
10. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators and infliximab in inflammatory bowel disease. Gastroenterology 2006 130 : 935 9.
11. Porro GB, Cassinotti A, Ferrara E, Maconi G, Ardizzone S. Review article: the management of steroid dependency in ulcerative colitis. Aliment. Pharmacol. Ther. 2007 26 : 779 94.
12. Bean RH. The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med. J. Aust. 1962 49 : 592 3.
13. Bowen GE, Irons GV, Rhodes JB. Early experiences with azathioprine in ulcerative colitis. A note of caution. JAMA 1966 195 : 460 4.
14. Lichtiger S, Present DH, Kornbluth A. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N. Engl. J. Med. 1994 330 : 1841 5.
15. Su C, Lichtenstein GR. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Gastroenterol. Clin. North Am. 2004 33 : 209 34, viii.
16. Yamaji K, Fukunaga K, Yamane S, Sueoka A, Nose Y. Current therapeutic apheresis technologies for inflammatory bowel disease. Ther. Apher. 1998 2 : 105 8.
17. Kawamura A, Saitoh M, Yonekawa M et al. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease. Ther. Apher. 1999 3 : 334 7.
18. Shimoyama T, Sawada Y, Tanaka T, Saito Y, Munakata A, Toyoda T. Granulocytapheresis in active ulcerative colitis. A multicenter randomized control study. Jpn J. Apher. 1999 18 : 117 31.
19. Sawada K, Muto T, Shimoyama T et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr. Pharm. Des. 2003 9 : 307 21.
20. Saniabadi AR, Hanai H, Takeuchi K et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther. Apher. Dial. 2003 7 : 48 59.
21. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig. Dis. Sci. 2004 49 : 565 71.
22. Sawada K, Kazuo K, Suzuki Y et al. Leukocytapheresis in ulcerative colitis: results of multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am. J. Gastroenterol. 2005 100 : 1362 9.
23. Kruis W, Dignass A, Steinhagen-Thiessen E et al. Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J. Gastroenterol. 2005 11 : 7001 6.
24. Bresci G, Parisi G, Bertoni M, Mazzoni A, Scatena F, Capria A. Treatment with granulocytapheresis of active steroid-refractory inflammatory bowel diseases. Our experience with a prospective study. World J. Gastroenterol. 2006 12 : 2201 4.
25. D'Ovidio V, Aratari A, Viscido A et al. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig. Liver Dis. 2006 38 : 389 94.
26. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. 1989 24 : 2 6.
27. Rachmilewitz D. Coated mesalazine versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br. Med. J. 1989 298 : 82 6.
28. Panes J, Guilera M, Ginard D et al. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? Dig. Liver Dis. 2007 39 : 617 25. Epub 2007 May 24.
29. Ljiung T. Granulocyte, monocyte/macrophage apheresis for IBD: the first 100 patients treated in Scandinavia. Scand. J. Gastroenterol. 2007 42 : 221 7.
30. Cabriada JL, Domenech E. Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease. Gastroenterol. Hepatol. 2006 29 : 85 92.